AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,049 | -27.1% | 15 | -25.0% | 0.00% | -100.0% |
Q2 2023 | $1,438 | +16.5% | 20 | 0.0% | 0.00% | – |
Q1 2023 | $1,234 | -98.4% | 20 | -98.0% | 0.00% | -100.0% |
Q4 2022 | $78,673 | +87.3% | 1,020 | -7.3% | 0.03% | +60.0% |
Q3 2022 | $42,000 | 0.0% | 1,100 | 0.0% | 0.02% | +17.6% |
Q2 2022 | $42,000 | -16.0% | 1,100 | -8.3% | 0.02% | -5.6% |
Q1 2022 | $50,000 | +47.1% | 1,200 | +33.3% | 0.02% | +38.5% |
Q4 2021 | $34,000 | +13.3% | 900 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $30,000 | – | 900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |